Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty

American Heart Journal

Volumn 148, Issue 4, 2004, Pages 655-662

  Grabowski, Marcin ^a   Filipiak, Krzysztof J ^a   Karpinski, Grzegorz ^a   Wretowski, Dominik ^a   Rdzanek, Adam ^a   Huczek, Zenon ^a   Horszczaruk, Grzegorz J ^a   Kochman, Janusz ^a   Rudowski, Robert ^a   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; THROMBOSIS;

ADULT; AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS;

EID: 5344245383     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.04.023     Document Type: Article

References (19)

1. Valli N., Gobinet A., Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med. 134:1999;437-444
2. Mark D.B., Felker G.M. B-type natriuretic peptide a biomarker for all seasons? N Engl J Med. 350:2004;718-720
3. Morrow D.A., de Lemos J.A., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 41:2003;1264-1272
4. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with ACS. N Engl J Med. 345:2001;1014-1021
5. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term death in acute coronary syndromes. Circulation. 106:2002;2913-2918
6. Rezkalla S.H., Kloner R.A. No-reflow phenomenon. Circulation. 105:2002;656-662
7. Stone G.W., Peterson M.A., Lansky A.J., et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol. 39:2002;591-597
8. Mair J., Hammerer-Lercher A., Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 39:2001;571-588
9. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I findings: TIMI Study Group. N Engl J Med 1985312:932-6
10. Wilson R.F., Lasson D.D., Lesser J.R., et al. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet. 1:1989;807-811
11. Eeckhout M., Kern M.J. The coronary no-reflow phenomenon a review of mechanism and therapies. Eur Heart J. 22:2001;729-739
12. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction a convenient, bedside, clinical score for risk assessment at presentation an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 102:2000;2031-2037
13. Reffelmann T., Hale S.L., Li G., et al. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 282:2002;H766-772
14. Inoue T., Sakuma M., Yaguchi I., et al. Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction. Am Heart J. 143:2002;790-796
15. Yip H.K., Chen M.C., Chang H.W., et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction predictors of slow-flow and no-reflow phenomenon. Chest. 122:2002;1322-1332
16. Goetze J.P., Christoffersen C., Perko M., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J. 17:2003;1105-1107
17. Tateishi J., Masutani M., Ohyanagi M., et al. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol. 23:2000;776-780
18. Morishima I., Sone T., Tsuboi H., et al. Plasma C-reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty comparison with brain natriuretic peptide. Clin Cardiol. 25:2002;112-116
19. Resnic F.S., Wainstein M., Lee M.K., et al. No-reflow is and independent predictor of death and myocardial infarction after percutaneous coronary interventions. Am Heart J. 145:2003;42-46